Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
about
Efflux-mediated drug resistance in bacteria: an updateA balancing act: efflux/influx in mycobacterial drug resistanceCurrent prospects for the fluoroquinolones as first-line tuberculosis therapyComparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from RussiaPolyamines inhibit porin-mediated fluoroquinolone uptake in mycobacteriaIdentification of new drug targets and resistance mechanisms in Mycobacterium tuberculosisGenome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug ResistanceThe role of selection in shaping diversity of natural M. tuberculosis populationsXenobiotic efflux in bacteria and fungi: a genomics updateREMap: Operon map of M. tuberculosis based on RNA sequence dataIdentification of novel leads applying in silico studies for Mycobacterium multidrug resistant (MMR) protein.Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake.Uncovering new signaling proteins and potential drug targets through the interactome analysis of Mycobacterium tuberculosis.New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in MycobacteriaInterplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosisThe structural modeling of the interaction between levofloxacin and the Mycobacterium tuberculosis gyrase catalytic site sheds light on the mechanisms of fluoroquinolones resistant tuberculosis in Colombian clinical isolates.Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.Comparative genomic analysis of Mycobacterium tuberculosis clinical isolates.Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.Disclosure of selective advantages in the "modern" sublineage of the Mycobacterium tuberculosis Beijing genotype family by quantitative proteomicsClinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaEliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs).Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas.Response of Staphylococcus aureus to salicylate challenge.Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.Proteasome Accessory Factor C (pafC) Is a novel gene Involved in Mycobacterium Intrinsic Resistance to broad-spectrum antibiotics--Fluoroquinolones.A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy.A predicted operon map for Mycobacterium tuberculosis.Efflux-mediated antimicrobial resistance.Eagle Effect in Nonreplicating Persister MycobacteriaRole of mycobacterial efflux transporters in drug resistance: an unresolved question.Rapid identification of extensively and extremely drug resistant tuberculosis from multidrug resistant strains; using PCR-RFLP and PCR-SSCP.Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.The role of transport mechanisms in mycobacterium tuberculosis drug resistance and tolerance.Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.
P2860
Q24609407-02026BCC-B726-496F-97E9-806C6B1D547BQ24644870-2145905E-E8CD-47B2-9479-F0F7B67782FCQ26823843-3121C76C-7DEB-475D-B17E-0792CDC9A898Q28486275-8FA6CDC0-D835-47FF-8DC6-20F51DA73B48Q28533601-EDB4CA6A-3D9B-4669-BA86-0F40E3B5C9FEQ28533721-3EC19DB6-14CB-4231-A814-16239E31244AQ28545741-D148E61A-7F9F-44DF-A22A-E89BF54EADD7Q28681931-70D3C53C-B207-461C-8DE1-FDE4254052F2Q28834633-99F31C09-E780-4ED6-9C44-B4E5AB3E0AB7Q31116999-F5CE1811-00B2-43C2-89E7-75794A350B53Q31141792-CB76B474-3840-4682-A776-157064E66AEAQ33335973-094E3B6C-FF70-4A4E-B02A-C739F7883805Q33419727-12A545FC-147D-42A4-8795-2E447CD1D6CEQ33600161-AFFC154E-9AB0-4289-ACB7-CD622F4FE47EQ33607162-0AFEB610-227E-417F-B513-36BBA9138616Q33616718-FA34492E-E490-483D-9CC0-1496454F095FQ33798280-4ADFC326-8F19-4364-951F-00AD441CF972Q33805218-D6B5FBB9-1CE7-4936-B408-4CD407D6B425Q33962755-F96F2510-F077-4B3D-B438-AC29732DA7B1Q34303366-3874E5B2-AAA3-475E-9FB8-CB2007894C8EQ34647294-8B9A588B-D57F-4C9E-BC2E-ACDB447C18FEQ35034180-3804066E-E4A6-43EF-81D0-9956264D73BFQ35139691-42EBEC6D-96E7-40AE-AC8B-53DCA32589E6Q35634244-265052EF-86D2-4697-834F-760439AE1928Q35636012-D4E595AE-A30A-4433-8CF9-3210833ED716Q35814202-687089B5-96E0-4FDD-8BDE-16133BDAE7C3Q35821755-7C043DF4-E2C5-4BCA-AC55-FE6257AA8F73Q35867806-71F4E7E2-5813-4017-9580-DBF32C072D81Q35983023-7A0C7E88-00E4-4F96-8742-D71EC624C2CFQ35990883-99C394E9-E852-4025-AA73-B1BF9C850DC3Q36138147-6487BCD9-DF31-4E82-82CD-29A71B86E57CQ36290556-77F32F37-B5AC-4D07-BF99-740B3DF97087Q36378353-8EBB36E4-2F98-4B91-97A7-C2E3D81F68C0Q36425928-2B2E38AB-FB95-4A3D-80C9-37B78E39E81BQ36558506-5B1F108C-9156-46B8-BF84-FF492B699329Q37036485-3AA58D10-FC56-44ED-B0E5-C7CF5350DA3BQ37274766-CF3E91EF-A418-40DD-8284-58A08D1E1541Q37277325-30146FDD-DB0E-49FB-91F1-BF677C4096C7Q37385024-7D8AB488-3E57-4DF5-BF7A-E8979FDC1679Q37392763-561664C8-9945-4BB7-BCFA-D4EC567C0204
P2860
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
description
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im August 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/08/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/08/01)
@nl
наукова стаття, опублікована в серпні 2004
@uk
مقالة علمية (نشرت في أغسطس 2004)
@ar
name
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
@ast
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
@en
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
@nl
type
label
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
@ast
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
@en
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
@nl
prefLabel
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
@ast
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
@en
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
@nl
P2093
P2860
P50
P3181
P1476
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
@en
P2093
Edda De Rossi
Fabio Arcesi
Paola Guglierame
P2860
P304
P3181
P356
10.1128/AAC.48.8.3175-3178.2004
P407
P577
2004-08-01T00:00:00Z